tiprankstipranks
Trending News
More News >
Aegon Nv (AEG)
:AEG

Aegon (AEG) AI Stock Analysis

Compare
573 Followers

Top Page

AEG

Aegon

(NYSE:AEG)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
$7.50
▼(-4.58% Downside)
Aegon's stock score is driven by a solid valuation and positive earnings call, indicating strategic progress and shareholder returns. Financial performance shows recovery, but technical indicators suggest caution due to bearish trends.
Positive Factors
Strategic Relocation to US
Relocating to the US strengthens Aegon's market position in its largest operational region, potentially enhancing competitive advantages and growth opportunities.
Strong Operating Results
Improved operating results indicate robust business growth and effective management, supporting long-term profitability and market competitiveness.
Expansion of Share Buyback Program
Expanding the share buyback program reflects confidence in financial health and commitment to enhancing shareholder value over the long term.
Negative Factors
Decrease in Operating Capital Generation
A decline in operating capital generation may indicate challenges in sustaining business operations and funding growth initiatives.
Decrease in Group Solvency Ratio
A lower solvency ratio can impact financial stability and limit the company's ability to absorb shocks, posing risks to long-term resilience.
Impact of Exchange Rate Movements
Exchange rate fluctuations can affect financial results and valuation, potentially complicating financial planning and performance assessment.

Aegon (AEG) vs. SPDR S&P 500 ETF (SPY)

Aegon Business Overview & Revenue Model

Company DescriptionAegon N.V. is a multinational life insurance, pensions, and asset management company headquartered in The Hague, Netherlands. The company operates in various sectors, primarily focusing on providing financial services including life insurance, retirement solutions, and investment management. Aegon's core products include individual and group life insurance, annuities, pensions, and various investment products tailored to meet the needs of both individual and institutional clients across its global market presence.
How the Company Makes MoneyAegon generates revenue through several key streams. The primary source is the premiums collected from life insurance policies and annuities, which contribute significantly to its income. Additionally, the company earns money through investment management fees from its asset management division, where it manages investments for both retail and institutional clients. Aegon also benefits from fees related to pension products and services. Significant partnerships with financial institutions and distribution networks enhance its reach and customer base, further contributing to its earnings. Overall, the combination of these revenue streams, along with prudent investment strategies, positions Aegon to achieve sustainable profitability.

Aegon Earnings Call Summary

Earnings Call Date:Aug 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Feb 19, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong operating results and strategic initiatives such as dividend increases and share buybacks, but also noted challenges like decreased operating capital generation and the impact of exchange rate movements.
Q2-2025 Updates
Positive Updates
Strong Operating Results
Operating result was EUR 845 million, up 19% compared with last year, driven by profitable business growth and improved claims experience in the U.S., U.K., and International segment.
Increased Interim Dividend
Interim dividend increased by EUR 0.03 compared with last year to EUR 0.19 per common share.
Expansion of Share Buyback Program
Announced a EUR 200 million increase to the current share buyback program, totaling EUR 400 million of shares during the second half of 2025.
Strong Commercial Momentum in the Americas
Transamerica's new life sales increased by 13% in the Individual Life business, with a 14% increase in the number of licensed agents.
Solid Free Cash Flow
Free cash flow in the first half of 2025 amounted to EUR 442 million, a significant increase compared to EUR 373 million last year.
Negative Updates
Decrease in Operating Capital Generation
Operating capital generation before holding and funding expenses amounted to EUR 576 million, decreasing by 2% over the same period.
Decrease in Group Solvency Ratio
Group solvency ratio decreased by 5 percentage points compared with year-end 2024 to 183%.
Impact of Exchange Rate Movements
Valuation equity per share decreased by 5 percentage points over the first half of 2025 due to the impact of unfavorable exchange rate movements.
Company Guidance
During Aegon's First Half 2025 Results Conference Call, the company reported significant progress towards its strategic goals. The operating result was EUR 845 million, marking a 19% increase from the previous year, driven by profitable business growth and improved claims experience in key markets. Operating capital generation before holding and funding expenses slightly decreased by 2% to EUR 576 million, while new business strain increased, particularly in U.S. strategic assets. The U.S. division performed well, with a 13% increase in new life sales and a near doubling of net deposits for the RILA product. Aegon's cash capital holding was over EUR 2 billion, bolstered by remittances and the completion of a EUR 150 million share buyback. The interim dividend was raised by EUR 0.03 to EUR 0.19 per share, and the share buyback program was expanded by EUR 200 million, totaling EUR 400 million for the second half of 2025. Additionally, Aegon is reviewing the potential relocation of its head office to the U.S., considering the country's significant contribution to its operations and strategic focus. The company remains on track to meet its financial targets for 2025.

Aegon Financial Statement Overview

Summary
Aegon shows a recovery in profitability with a positive swing in net income and improved net profit margin. The balance sheet is stable with moderate leverage, but challenges in equity retention persist. Cash flow conversion is improving, though operational efficiency has room for growth.
Income Statement
64
Positive
Aegon's income statement shows signs of recovery with a significant positive swing in net income from a loss in previous years to a profit in 2024. The gross profit margin remains consistent as total revenue equals gross profit, indicating no direct costs of goods sold. However, revenue has been volatile, with a sharp decline in recent years followed by a recovery. The net profit margin improved from negative to a positive 3.52% in 2024.
Balance Sheet
58
Neutral
The balance sheet reflects a moderate financial structure with a debt-to-equity ratio of 0.54 in 2024, indicating reasonable leverage. However, stockholders' equity has seen a decline over the years, suggesting potential pressure on financial stability. The equity ratio is at 2.81%, highlighting a low proportion of equity financing relative to assets.
Cash Flow
60
Neutral
Cash flow analysis shows a positive trend in free cash flow, despite a decline in operating cash flow from 2023 to 2024. The free cash flow to net income ratio is favorable, suggesting effective cash conversion. However, the operating cash flow to net income ratio is at 1.11, indicating room for improvement in operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.95B19.52B12.98B-21.64B46.50B40.65B
Gross Profit22.95B19.52B2.37B14.29B46.50B40.65B
EBITDA-5.59B635.00M-204.00M1.00B2.58B169.00M
Net Income1.30B688.00M-179.00M-570.00M1.98B45.00M
Balance Sheet
Total Assets310.63B327.39B301.58B401.79B468.25B443.81B
Cash, Cash Equivalents and Short-Term Investments53.68B58.18B4.07B64.31B108.25B109.00B
Total Debt4.27B5.00B4.92B6.67B12.23B11.07B
Total Liabilities301.25B318.08B292.03B387.60B441.88B419.15B
Stockholders Equity9.26B9.19B7.55B10.76B26.18B24.59B
Cash Flow
Free Cash Flow-116.00M711.00M799.00M2.75B-1.91B-2.97B
Operating Cash Flow-61.00M762.00M864.00M2.85B-1.80B-2.85B
Investing Cash Flow447.00M300.00M-2.00B616.00M-54.00M-139.00M
Financing Cash Flow-1.48B-1.75B-3.24B-1.83B300.00M-778.00M

Aegon Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.86
Price Trends
50DMA
7.61
Negative
100DMA
7.59
Negative
200DMA
7.03
Positive
Market Momentum
MACD
-0.04
Positive
RSI
47.12
Neutral
STOCH
47.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AEG, the sentiment is Negative. The current price of 7.86 is above the 20-day moving average (MA) of 7.67, above the 50-day MA of 7.61, and above the 200-day MA of 7.03, indicating a neutral trend. The MACD of -0.04 indicates Positive momentum. The RSI at 47.12 is Neutral, neither overbought nor oversold. The STOCH value of 47.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AEG.

Aegon Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$34.88B9.0017.81%16.68%-28.54%
78
Outperform
$38.74B11.3620.07%1.55%7.11%22.52%
76
Outperform
$19.54B12.9513.74%3.46%12.33%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
64
Neutral
$11.35B8.3214.42%5.86%-6.19%
60
Neutral
$46.42B15.427.68%2.03%-23.02%52.43%
40
Underperform
$13.76B-17.35-41.33%2.19%7.70%-155.12%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AEG
Aegon
7.54
2.00
36.10%
AIG
American International Group
86.03
15.08
21.25%
ACGL
Arch Capital Group
96.20
4.11
4.46%
HIG
Hartford Insurance
139.01
31.11
28.83%
PFG
Principal Financial
88.95
14.44
19.38%
EQH
Equitable Holdings
48.02
2.00
4.35%

Aegon Corporate Events

Aegon Announces Strategic Move to US, Rebranding as Transamerica
Dec 10, 2025

On December 10, 2025, Aegon announced its strategic plan to relocate its head office and legal seat to the US, renaming itself Transamerica Inc. by January 1, 2028. This move aims to strengthen its position in the US life insurance market, which represents 70% of its operations. The transition involves a strategic review of Aegon UK, a reinsurance transaction to reduce capital employed, and a new share buyback program. The relocation will incur an estimated one-time cost of EUR 350 million, with the company planning to report under US GAAP by 2027. This decision is expected to have significant organizational implications, particularly for its head office in the Netherlands, and requires shareholder approval in 2026.

Aegon Ltd. Reports Strong Q3 2025 Results and Strategic Growth
Nov 13, 2025

Aegon Ltd. reported a strong third quarter in 2025, with an operating capital generation of EUR 340 million and cash capital at holding of EUR 1.9 billion. The company successfully sold 12.5 million shares in a.s.r. for EUR 700 million and is on track to meet its financial targets for the year. Despite net outflows in its UK platform business, Aegon saw significant growth in its US Strategic Assets, with a 39% increase in Individual Life sales and expanded market share in the World Financial Group. The company remains well-capitalized and anticipates further strategic updates at its upcoming Capital Markets Day.

Aegon Announces Board Leadership Changes Effective November 2025
Nov 3, 2025

On November 3, 2025, Aegon announced changes to its Board of Directors, with David Herzog set to succeed William Connelly as Chairman on November 13, 2025. Connelly will retire from his position on the same date. Additionally, Aegon plans to propose Leni Boeren as a new board member at the 2026 Annual General Meeting. Boeren brings extensive experience from her roles in the financial services industry, including positions at Kempen Capital Management and Robeco Groep. These changes are expected to support Aegon’s strategic goals and ongoing transformation efforts.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025